Business
HEALWELL AI Provides Additional Information Regarding November 3, 2025, Release Where it Announced Strategic Divestments
Toronto, Ontario--(Newsfile Corp. - December 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL AI Provides Additional Information Regarding November 3, 2025, Release Where it Announced Strategic DivestmentsToronto, Ontario--(Newsfile Corp. - December 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is issuing this press release at the request of the Ontario Securities Commission, pursuant to an ongoing disclosure review, to provide additional information on certain statements included in its press release dated November 3, 2025 (the \"November 3rd Release\") where it announced a number of strategic divestments. This information is intended to provide additional context regarding forward-looking information and certain qualitative descriptive statements included in that disclosure.This press release references \"Adjusted EBITDA\", which is a non-IFRS financial measure and should be considered together with, and not as a substitute for, the most directly comparable IFRS financial measure (Net Income). For additional information regarding the definition, reconciliation and discussion of the usefulness and limitations of Adjusted EBITDA, readers should refer to the Company's most recent management's discussion and analysis available on SEDAR+ at www.sedarplus.com. Clarification of Forward-Looking Information Related to Revenue Run-Rate and Adjusted EBITDAThe November 3rd Release related to the completion of three strategic transactions in which the Company sold two of its non-core businesses and contributed two more non-core businesses to a newly formed clinical research joint venture. In the November 3rd Release, the Company stated that: \"Together these transactions allow HEALWELL to become a pure-play digital SaaS, services and AI business, primarily focused on health systems and large enterprises globally with a revenue run-rate of approximately $120 million annually and is profitable on an Adjusted EBITDA basis\" (the \"FLI Statement\"). The Company notes that the FLI Statement constitutes forward-looking information within the meaning of applicable Canadian securities laws and, as such, was based on management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable ...